BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for Sept. 27, 2022

Sep. 27, 2022
Biopharmas raising money in public or private financings, including: Exicure, Prime, Sanity, Tavros.
Read More

Financings for Sept. 26, 2022

Sep. 26, 2022
Med-tech firms raising money in public or private financings, including: Surge.
Read More

Financings for Sept. 26, 2022

Sep. 26, 2022
Biopharmas raising money in public or private financings, including: Anebulo, Damona, Fennec, RS.
Read More

Koutech completes financing to develop robots for microsurgery

Sep. 23, 2022
By Doris Yu
Koutech Medical Robotics (Shanghai) Co. Ltd. reported it has raised “hundreds of millions of yuan” in a series A round to support the development of its surgical robot. The round is led by Qiming Venture Partners.
Read More

Financings for Sept. 23, 2022

Sep. 23, 2022
Med-tech firms raising money in public or private financings, including: Edap, Theralase Technologies.
Read More

Financings for Sept. 23, 2022

Sep. 23, 2022
Biopharmas raising money in public or private financings, including: Aadi, Cadrenal, CASI, Spectrum, Trevi, Virios.
Read More
Smartphone with website of Shanghai STAR Market in front of logo

Innocare raises ¥2.92B in Shanghai IPO, but shares fall on debut

Sep. 22, 2022
By Doris Yu
Innocare Pharma Ltd. raised ¥2.92 billion (US$412 million) in a second listing on the Shanghai STAR Market. Its shares opened at ¥10.86 apiece, sliding 15.4% to close at ¥9.33 on the first trading day, Sept. 21. The company will use the proceeds to support cancer and autoimmune drug R&D, improve its drug development platform, build its sales network, and upgrade its information technology, said Chief Commercial Officer Jin Xiaodong.
Read More

Financings for Sept. 22, 2022

Sep. 22, 2022
Med-tech firms raising money in public or private financings, including: Agilis Robotics, US Medical Innovations.
Read More

Financings for Sept. 22, 2022

Sep. 22, 2022
Biopharmas raising money in public or private financings, including: Altay, Mediwound, Melt, Rivus, Roca.
Read More

Financings for Sept. 21, 2022

Sep. 21, 2022
Med-tech firms raising money in public or private financings, including: Know Labs, Medtronic, Microtransponder.
Read More
Previous 1 2 … 337 338 339 340 341 342 343 344 345 … 667 668 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing